| Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. JS Haurum, G Arsequell, AC Lellouch, SY Wong, RA Dwek, AJ McMichael, ... The Journal of experimental medicine 180 (2), 739-744, 1994 | 215 | 1994 |
| Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL MH Andersen, JE Bonfill, A Neisig, G Arsequell, I Søndergaard, J Neefjes, ... The Journal of Immunology 163 (7), 3812-3818, 1999 | 167 | 1999 |
| Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity A Glithero, J Tormo, JS Haurum, G Arsequell, G Valencia, J Edwards, ... Immunity 10 (1), 63-74, 1999 | 164 | 1999 |
| Recent advances in the synthesis of complex N-glycopeptides G Arsequell, G Valencia Tetrahedron: Asymmetry 10 (16), 3045-3094, 1999 | 143 | 1999 |
| Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo JS Haurum, IB Høier, G Arsequell, A Neisig, G Valencia, J Zeuthen, ... The Journal of experimental medicine 190 (1), 145-150, 1999 | 120 | 1999 |
| Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative MR Almeida, B Macedo, I Cardoso, I Alves, G Valencia, G Arsequell, ... Biochemical Journal 381 (2), 351-356, 2004 | 115 | 2004 |
| O-glycosyl α-amino acids as building blocks for glycopeptide synthesis G Arsequell, G Valencia Tetrahedron: Asymmetry 8 (17), 2839-2876, 1997 | 113 | 1997 |
| Synthetic glycosylation of proteins using N-(β-saccharide) iodoacetamides: applications in site-specific glycosylation and solid-phase enzymic oligosaccharide … SY Wong, GR Guile, RA Dwek, G Arsequell Biochemical Journal 300 (3), 843-850, 1994 | 85 | 1994 |
| Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition JS Haurum, L Tan, G Arsequell, P Frodsham, AC Lellouch, PAH Moss, ... European journal of immunology 25 (12), 3270-3276, 1995 | 83 | 1995 |
| Arylation of Phe and Tyr side chains of unprotected peptides by a Suzuki− Miyaura reaction in Water M Vilaró, G Arsequell, G Valencia, A Ballesteros, J Barluenga Organic Letters 10 (15), 3243-3245, 2008 | 73 | 2008 |
| Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor L Gales, S Macedo-Ribeiro, G Arsequell, G Valencia, MJ Saraiva, ... Biochemical Journal 388 (2), 615-621, 2005 | 73 | 2005 |
| Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors A González, J Quirante, J Nieto, MR Almeida, MJ Saraiva, A Planas, ... Bioorganic & medicinal chemistry letters 19 (17), 5270-5273, 2009 | 66 | 2009 |
| Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors T Mairal, J Nieto, M Pinto, MR Almeida, L Gales, A Ballesteros, ... PLoS One 4 (1), e4124, 2009 | 65 | 2009 |
| Sex pheromone biosynthesis in the processionary moth Thaumetopoea pityocampa by delta‐13 desaturation G Arsequell, G Fabriàs, F Camps Archives of insect biochemistry and physiology 14 (1), 47-56, 1990 | 59 | 1990 |
| Regioselective postsynthetic modification of phenylalanine side chains of peptides leading to uncommon ortho-iodinated analogues G Espuña, G Arsequell, G Valencia Parera, J Barluenga, ... John Wiley & Sons, 2004 | 58 | 2004 |
| Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse … CA Ribeiro, SM Oliveira, LF Guido, A Magalhaes, G Valencia, G Arsequell, ... Journal of Alzheimer's Disease 39 (2), 357-370, 2014 | 53 | 2014 |
| Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors I Dolado, J Nieto, MJM Saraiva, G Arsequell, G Valencia, A Planas Journal of Combinatorial Chemistry 7 (2), 246-252, 2005 | 53 | 2005 |
| Undiscovered roles for transthyretin: from a transporter protein to a new therapeutic target for Alzheimer’s disease T Gião, J Saavedra, E Cotrina, J Quintana, J Llop, G Arsequell, I Cardoso International journal of molecular sciences 21 (6), 2075, 2020 | 48 | 2020 |
| Lectin purified human class I MHC‐derived peptides: evidence for presentation of glycopeptides in vivo IB Kastrup, S Stevanovic, G Arsequell, G Valencia, J Zeuthen, ... Tissue Antigens 56 (2), 129-135, 2000 | 47 | 2000 |
| Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design I Cardoso, MR Almeida, N Ferreira, G Arsequell, G Valencia, MJ Saraiva Biochemical Journal 408 (1), 131-138, 2007 | 41 | 2007 |
